A critical advance in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in several forms of malignancies, causing https://top10bookmark.com/story21796839/mini-antibodies-reactivate-p53-new-new-pathway-for-tumor-therapy